Thyroid Disorders in Older Adults

Endocrinology and Metabolism Clinics of North America

Volumn 42, Issue 2, 2013, Pages 287-303

  Visser, W Edward ^a   Visser, Theo J ^a   Peeters, Robin P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hyperthyroidism; Hypothyroidism; Nonthyroidal illness; Subclinical hyperthyroidism; Subclinical hypothyroidism; Thyroid function tests; TSH reference range

Indexed keywords

AMIODARONE; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; FUROSEMIDE; GLUCOCORTICOID; HEPARIN; LEVOTHYROXINE; LIOTHYRONINE; LITHIUM; PROPRANOLOL; RADIOACTIVE IODINE; THYROID ANTIBODY; THYROTROPIN; THYROXINE; THYROXINE DEIODINASE;

AGED; CLINICAL FEATURE; DIAGNOSTIC ERROR; DISEASE CLASSIFICATION; DRUG MEGADOSE; GRAVES DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MORTALITY; OSTEOPOROSIS; PRIORITY JOURNAL; REFERENCE VALUE; REVIEW; SYMPTOM; TACHYCARDIA; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

AGING; ANIMALS; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; PITUITARY GLAND; THYROID DISEASES; THYROID GLAND; THYROTROPIN;

EID: 84878150294     PISSN: 08898529     EISSN: 15584410     Source Type: Journal    
DOI: 10.1016/j.ecl.2013.02.008     Document Type: Review

References (86)

1. Russell S.J., Kahn C.R. Endocrine regulation of ageing. Nat Rev Mol Cell Biol 2007, 8:681-691.
2. Mariotti S., Franceschi C., Cossarizza A., et al. The aging thyroid. Endocr Rev 1995, 16:686-715.
3. Boucai L., Surks M.I. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009, 70:788-793.
4. Hollowell J.G., Staehling N.W., Flanders W.D., et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002, 87:489-499.
5. Surks M.I., Hollowell J.G. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 2007, 92:4575-4582.
6. Hoogendoorn E.H., Hermus A.R., de Vegt F., et al. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin Chem 2006, 52:104-111.
7. Bremner A.P., Feddema P., Leedman P.J., et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab 2012, 97:1554-1562.
8. Waring A.C., Arnold A.M., Newman A.B., et al. Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study. J Clin Endocrinol Metab 2012, 97:3944-3950.
9. Gregerman R.I., Gaffney G.W., Shock N.W., et al. Thyroxine turnover in euthyroid man with special reference to changes with age. J Clin Invest 1962, 41:2065-2074.
10. Rosenbaum R.L., Barzel U.S. Levothyroxine replacement dose for primary hypothyroidism decreases with age. Ann Intern Med 1982, 96:53-55.
11. Sawin C.T., Herman T., Molitch M.E., et al. Aging and the thyroid. Decreased requirement for thyroid hormone in older hypothyroid patients. Am J Med 1983, 75:206-209.
12. Bianco A.C., Salvatore D., Gereben B., et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002, 23:38-89.
13. Peeters R.P., van den Beld A.W., van Toor H., et al. A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. J Clin Endocrinol Metab 2005, 90:256-263.
14. Silvestri E., Lombardi A., de Lange P., et al. Age-related changes in renal and hepatic cellular mechanisms associated with variations in rat serum thyroid hormone levels. Am J Physiol Endocrinol Metab 2008, 294:E1160-E1168.
15. Mooradian A.D. The hepatic transcellular transport of 3,5,3'-triiodothyronine is reduced in aged rats. Biochim Biophys Acta 1990, 1054:1-7.
16. Mariotti S., Sansoni P., Barbesino G., et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet 1992, 339:1506-1508.
17. Mariotti S., Barbesino G., Caturegli P., et al. Complex alteration of thyroid function in healthy centenarians. J Clin Endocrinol Metab 1993, 77:1130-1134.
18. Atzmon G., Barzilai N., Hollowell J.G., et al. Extreme longevity is associated with increased serum thyrotropin. J Clin Endocrinol Metab 2009, 94:1251-1254.
19. Atzmon G., Barzilai N., Surks M.I., et al. Genetic predisposition to elevated serum thyrotropin is associated with exceptional longevity. J Clin Endocrinol Metab 2009, 94:4768-4775.
20. Rozing M.P., Westendorp R.G., de Craen A.J., et al. Low serum free triiodothyronine levels mark familial longevity: the Leiden Longevity Study. J Gerontol A Biol Sci Med Sci 2010, 65:365-368.
21. Gussekloo J., van Exel E., de Craen A.J., et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 2004, 292:2591-2599.
22. Rodondi N., den Elzen W.P., Bauer D.C., et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010, 304:1365-1374.
23. Peeters R.P., Debaveye Y., Fliers E., et al. Changes within the thyroid axis during critical illness. Crit Care Clin 2006, 22:41-55. vi.
24. Peeters R.P., Wouters P.J., van Toor H., et al. Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. J Clin Endocrinol Metab 2005, 90:4559-4565.
25. Araujo R.L., Andrade B.M., da Silva M.L., et al. Tissue-specific deiodinase regulation during food restriction and low replacement dose of leptin in rats. Am J Physiol Endocrinol Metab 2009, 296:E1157-E1163.
26. van den Beld A.W., Visser T.J., Feelders R.A., et al. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J Clin Endocrinol Metab 2005, 90:6403-6409.
27. Forestier E., Vinzio S., Sapin R., et al. Increased reverse triiodothyronine is associated with shorter survival in independently-living elderly: the Alsanut study. Eur J Endocrinol 2009, 160:207-214.
28. Peeters R.P. Thyroid hormones and aging. Hormones (Athens) 2008, 7:28-35.
29. Surks M.I., Boucai L. Age- and race-based serum thyrotropin reference limits. J Clin Endocrinol Metab 2010, 95:496-502.
30. Baloch Z., Carayon P., Conte-Devolx B., et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126.
31. Surks M.I., Goswami G., Daniels G.H. The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005, 90:5489-5496.
32. Kahapola-Arachchige K.M., Hadlow N., Wardrop R., et al. Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf) 2012, 77:773-779.
33. Bahn R.S., Burch H.B., Cooper D.S., et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011, 21:593-646.
34. Garber J.R., Cobin R.H., Gharib H., et al. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association. Thyroid 2012, 18(6):988-1028.
35. Doucet J., Trivalle C., Chassagne P., et al. Does age play a role in clinical presentation of hypothyroidism?. J Am Geriatr Soc 1994, 42:984-986.
36. Trivalle C., Doucet J., Chassagne P., et al. Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc 1996, 44:50-53.
37. Almandoz J.P., Gharib H. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am 2012, 96:203-221.
38. Vanderpump M.P., Tunbridge W.M., French J.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995, 43:55-68.
39. Diez J.J. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J Gerontol A Biol Sci Med Sci 2002, 57:M315-M320.
40. Eskes S.A., Wiersinga W.M. Amiodarone and thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23:735-751.
41. Rhee C.M., Bhan I., Alexander E.K., et al. Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism. Arch Intern Med 2012, 172:153-159.
42. Martino E., Aghini-Lombardi F., Bartalena L., et al. Enhanced susceptibility to amiodarone-induced hypothyroidism in patients with thyroid autoimmune disease. Arch Intern Med 1994, 154:2722-2726.
43. Sawin C.T., Castelli W.P., Hershman J.M., et al. The aging thyroid. Thyroid deficiency in the Framingham Study. Arch Intern Med 1985, 145:1386-1388.
44. Roos A., Linn-Rasker S.P., van Domburg R.T., et al. The starting dose of levothyroxine in primary hypothyroidism treatment: a prospective, randomized, double-blind trial. Arch Intern Med 2005, 165:1714-1720.
45. Canaris G.J., Manowitz N.R., Mayor G., et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000, 160:526-534.
46. Parle J.V., Franklyn J.A., Cross K.W., et al. Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract 1993, 43:107-109.
47. Somwaru L.L., Arnold A.M., Joshi N., et al. High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over. J Clin Endocrinol Metab 2009, 94:1342-1345.
48. Cooper D.S., Biondi B. Subclinical thyroid disease. Lancet 2012, 379:1142-1154.
49. Surks M.I., Ortiz E., Daniels G.H., et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004, 291:228-238.
50. Bagchi N., Brown T.R., Parish R.F. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med 1990, 150:785-787.
51. Teng W., Shan Z., Teng X., et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006, 354:2783-2793.
52. Biondi B. Natural history, diagnosis and management of subclinical thyroid dysfunction. Best Pract Res Clin Endocrinol Metab 2012, 26:431-446.
53. Somwaru L.L., Rariy C.M., Arnold A.M., et al. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012, 97:1962-1969.
54. Biondi B., Cooper D.S. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008, 29:76-131.
55. Diez J.J., Iglesias P. Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure. J Clin Endocrinol Metab 2004, 89:4890-4897.
56. Walsh J.P., Bremner A.P., Feddema P., et al. Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 2010, 95:1095-1104.
57. Li Y., Teng D., Shan Z., et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 2008, 93:1751-1757.
58. de Jongh R.T., Lips P., van Schoor N.M., et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur J Endocrinol 2011, 165:545-554.
59. Roberts L.M., Pattison H., Roalfe A., et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction?. Ann Intern Med 2006, 145:573-581.
60. Simonsick E.M., Newman A.B., Ferrucci L., et al. Subclinical hypothyroidism and functional mobility in older adults. Arch Intern Med 2009, 169:2011-2017.
61. Lee J.S., Buzkova P., Fink H.A., et al. Subclinical thyroid dysfunction and incident hip fracture in older adults. Arch Intern Med 2010, 170:1876-1883.
62. Biondi B., Palmieri E.A., Fazio S., et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000, 85:4701-4705.
63. Rodondi N., Bauer D.C., Cappola A.R., et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol 2008, 52:1152-1159.
64. Razvi S., Weaver J.U., Vanderpump M.P., et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab 2010, 95:1734-1740.
65. Razvi S., Weaver J.U., Butler T.J., et al. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012, 172:811-817.
66. Goichot B., Vinzio S. Subclinical thyroid disorders. Lancet 2012, 380:335. [author reply: 336-7].
67. Mooijaart S.P. Subclinical thyroid disorders. Lancet 2012, 380:335. [author reply: 336-7].
68. Quinn T.J., Gussekloo J., Kearney P., et al. Subclinical thyroid disorders. Lancet 2012, 380:335-336. [author reply: 336-7].
69. Tunbridge W.M., Evered D.C., Hall R., et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 1977, 7:481-493.
70. Diez J.J. Hyperthyroidism in patients older than 55 years: an analysis of the etiology and management. Gerontology 2003, 49:316-323.
71. Laurberg P., Pedersen K.M., Vestergaard H., et al. High incidence of multinodular toxic goitre in the elderly population in a low iodine intake area vs. high incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of thyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Intern Med 1991, 229:415-420.
72. Gammage M.D., Parle J.V., Holder R.L., et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007, 167:928-934.
73. Heeringa J., Hoogendoorn E.H., van der Deure W.M., et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2008, 168:2219-2224.
74. Cobler J.L., Williams M.E., Greenland P. Thyrotoxicosis in institutionalized elderly patients with atrial fibrillation. Arch Intern Med 1984, 144:1758-1760.
75. Franklyn J.A., Boelaert K. Thyrotoxicosis. Lancet 2012, 379:1155-1166.
76. Mokshagundam S., Barzel U.S. Thyroid disease in the elderly. J Am Geriatr Soc 1993, 41:1361-1369.
77. Cappola A.R., Fried L.P., Arnold A.M., et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 2006, 295:1033-1041.
78. Vadiveloo T., Donnan P.T., Cochrane L., et al. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 2011, 96:E1-E8.
79. Laurberg P., Pedersen K.M., Hreidarsson A., et al. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab 1998, 83:765-769.
80. Meyerovitch J., Rotman-Pikielny P., Sherf M., et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med 2007, 167:1533-1538.
81. Parle J.V., Franklyn J.A., Cross K.W., et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991, 34:77-83.
82. Sawin C.T., Geller A., Kaplan M.M., et al. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991, 151:165-168.
83. Sawin C.T., Geller A., Wolf P.A., et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 331:1249-1252.
84. Sundbeck G., Eden S., Jagenburg R., et al. Thyroid dysfunction in 85-year-old men and women. Influence of non-thyroidal illness and drug treatment. Acta Endocrinol (Copenh) 1991, 125:475-486.
85. Ceresini G., Ceda G.P., Lauretani F., et al. Mild thyroid hormone excess is associated with a decreased physical function in elderly men. Aging Male 2011, 14:213-219.
86. Collet T.H., Gussekloo J., Bauer D.C., et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012, 172:799-809.